TY - JOUR
T1 - Mediator release during nasal provocation
T2 - A model to investigate the pathophysiology of rhinitis
AU - Togias, Alkis
AU - Naclerio, Robert M.
AU - Proud, David
AU - Baumgarten, Claus
AU - Peters, Stephen
AU - Creticos, Peter S.
AU - Warner, Jane
AU - Kagey-sobotka, Anne
AU - Adkinson, N. Franklin
AU - Norman, Philip S.
AU - Lichtenstein, Lawrence M.
N1 - Funding Information:
From the Division of Clinical Immunology, Departments of Medicine and Ototynolaryngology, Johns Hopkins University School of Medicine at Good Samaritan Hospital, Baltimore, Maryland. This work was supported by Grants Al-12810, Al-04866, CIRID-AI-20135, Al-07290, and HL-32272 from the National Institutes of Health. Dr. Naclerio is recipient of Teacher Development Investigator Award 1 K07-NS0081 l-01 from the National Institute of Neurolo$cal and Communicative Disorders and Stroke, and Dr. Peters is recipient of Clinical Investigator Award lK08-HL-01034 from the National Heart, Lung and Blood Institute, National Institutes of Health. Requests for reprints should be addressed to Dr. Lawrence M. Lichtenstein, Division of Clinical Immunology, Johns Hopkins Univ?rsity School of Medicine, Good Samaritan Hospital, 5601 Loch Raven Boulevard, Baltimore, Maryland 21239.
PY - 1985/12/20
Y1 - 1985/12/20
N2 - The pathogenesis of rhinitis was investigated using a model of nasal provocation with different types of stimuli. Allergic subjects had an immediate response to antigenic challenge with symptoms of rhinitis highly correlated with increments in the concentrations of histamine, prostaglandin D2, kinins and kininogens, leukotrienes, and toluene sulfonyl arginine methyl ester esterase activity in their nasal secretions. This reaction was abated by a tricyclic antihistamine also capable of inhibiting mediator release from human mast cells in vitro and, in some subjects, by disodium cromoglycate. In a number of patients, symptoms reappeared three to 12 hours after nasal provocation. This late reaction also involves release of all of the aforementioned mediators except for prostaglandin D2, and preliminary data suggest that it can be inhibited by oral or topical steroids. Cold; dry air can induce rhinitis with mast cell mediator release from selected subjects. The pathogenesis of this reaction is unclear, but there are indications that osmolarity changes are responsible for mast cell activation. Thus, mast cells can be induced to release mediators and cause nasal symptoms by both immunologic and physical mechanisms, which may account for the pathophysiology of several types of rhinitis.
AB - The pathogenesis of rhinitis was investigated using a model of nasal provocation with different types of stimuli. Allergic subjects had an immediate response to antigenic challenge with symptoms of rhinitis highly correlated with increments in the concentrations of histamine, prostaglandin D2, kinins and kininogens, leukotrienes, and toluene sulfonyl arginine methyl ester esterase activity in their nasal secretions. This reaction was abated by a tricyclic antihistamine also capable of inhibiting mediator release from human mast cells in vitro and, in some subjects, by disodium cromoglycate. In a number of patients, symptoms reappeared three to 12 hours after nasal provocation. This late reaction also involves release of all of the aforementioned mediators except for prostaglandin D2, and preliminary data suggest that it can be inhibited by oral or topical steroids. Cold; dry air can induce rhinitis with mast cell mediator release from selected subjects. The pathogenesis of this reaction is unclear, but there are indications that osmolarity changes are responsible for mast cell activation. Thus, mast cells can be induced to release mediators and cause nasal symptoms by both immunologic and physical mechanisms, which may account for the pathophysiology of several types of rhinitis.
UR - http://www.scopus.com/inward/record.url?scp=0022345888&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0022345888&partnerID=8YFLogxK
U2 - 10.1016/0002-9343(85)90084-1
DO - 10.1016/0002-9343(85)90084-1
M3 - Article
C2 - 4083296
AN - SCOPUS:0022345888
SN - 0002-9343
VL - 79
SP - 26
EP - 33
JO - The American journal of medicine
JF - The American journal of medicine
IS - 6 SUPPL. 1
ER -